Memorial Sloan Kettering Memorial Sloan Kettering (63)

New York, New York 10017

0 studies enrolling now · 1 studies all time

What they study most

CML

Studies at this site

• A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation — Completed